Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment.

< BACK TO ARCHIVE


2023 Jan 07


BMC Palliat Care


http://www.ncbi.nlm.nih.gov/pubmed/36609269?dopt=Abstract


22


1

Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment.

Authors

Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment.
Tsai J-H, Liu I-T, Su P-F, Huang Y-T, Chiu G-L, Chen Y-Y, Lai W-S, Lin P-C
BMC Palliat Care. 2023 Jan 07; 22(1):4.
PMID: 36609269.

Abstract

Limited efficacy has been observed when using opioids to treat neuropathic pain. Lidocaine patches reduce neuropathic pain in postherpetic neuralgia, but their benefits for cancer-related neuropathic pain remain unclear. This study aimed to investigate a treatment for cancer-related neuropathic pain.
Read This Paper